Table 2A.
Descriptive statistics for various parameters according to the readmission status
| Parameters | Readmission within 3 months | p value | ||
|---|---|---|---|---|
| No (n = 143) | Yes (n = 89) | |||
| 1 | Hb (M ± SD) | 9.33 ± 2.63 | 9.14 ± 2.72 | 0.602 |
| 2 | TLC (M ± SD) | 8472.24 ± 4297.7 | 12314.27 ± 6668.5 | <0.0001 |
| 3 | N (M ± SD) | 73.51 ± 11.3 | 78.33 ± 11.33 | 0.002 |
| 4 | Platelets (M ± SD) | 1.51 ± 0.99 | 1.14 ± 0.81 | 0.003 |
| 5 | T bilirubin (M ± SD) | 3.29 ± 4.34 | 10.53 ± 8.32 | <0.0001 |
| 6 | D bilirubin (M ± SD) | 1.93 ± 3.17 | 5.94 ± 5.39 | <0.0001 |
| 7 | AST (M ± SD) | 135.07 ± 648.36 | 162.37 ± 337.09 | 0.714 |
| 8 | ALT (M ± SD) | 78.55 ± 265.79 | 102.97 ± 261.4 | 0.494 |
| 9 | AST:ALT R (M ± SD) | 1.59 ± 0.63 | 2.05 ± 0.85 | <0.0001 |
| 10 | ALP (M ± SD) | 358.38 ± 336.88 | 329.17 ± 172 | 0.449 |
| 11 | Protein (M ± SD) | 6.11 ± 0.85 | 6.21 ± 0.8 | 0.364 |
| 12 | Albumin (M ± SD) | 3.19 ± 0.57 | 2.95 ± 0.57 | 0.003 |
| 13 | PT (M ± SD) | 19.31 ± 3.66 | 31.78 ± 12.82 | <0.0001 |
| 14 | INR (M ± SD) | 1.41 ± 0.32 | 2.54 ± 1.21 | <0.0001 |
| 15 | Urea (M ± SD) | 38.99 ± 23.04 | 50.84 ± 37.83 | 0.003 |
| 16 | Creatinine (M ± SD) | 1.05 ± 0.49 | 1.64 ± 1.33 | <0.0001 |
| 17 | Na (M ± SD) | 135.61 ± 6.98 | 133.29 ± 7.47 | 0.018 |
| 18 | K (M ± SD) | 4.16 ± 0.68 | 4.16 ± 1.02 | 0.963 |
| 19 | DF (M ± SD) | 27.76 ± 16.91 | 91.71 ± 60.48 | <0.0001 |
| 20 | MELD (M ± SD) | 14.36 ± 4.59 | 26.51 ± 8.0 | <0.0001 |
| 21 | CTP [no. (%)] A | 63 (44.1) | 4 (4.5) | <0.0001 |
| B | 67 (46.8) | 22 (24.7) | ||
| C | 13 (9.1) | 63 (70.8) | ||
M, mean; SD, standard deviation; HB, hemoglobin; INR, international normalized ratio; PT, prothrombin time; DF, discriminant function; MELD, model for end-stage liver disease; CTP, Child–Turcotte–Pugh; TLC, total leucocyte count; N, neutrophil; AST, aspartate transaminase; ALT, alanine transaminase; ALP, alkaline phosphatase; AST:ALT R, AST to ALT ratio
p values in boldface indicate statistical significance